Vidyya Medical News Service
Volume 5 Issue 104 Published - 14:00 UTC 08:00 EST 14-April-2003 Next Update - 14:00 UTC 08:00 EST 15-Apr-2003
little clear gif used for spacer

New drug regimen may offer alternative therapy to thousands of kidney transplant patients
On April 11, 2003, Wyeth Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved a new indication for the Company's immunosuppressant agent, Rapamune (sirolimus). Rapamune was approved in 1999 for the prophylaxis of organ rejection in renal transplant patients in combination with cyclosporine and corticosteroids. The new indication provides for withdrawal of cyclosporine from the immunosuppressive regimen two to four months after renal transplantation in patients at low to moderate immunologic risk.  more

Prescribing information: Rapamune (sirolimus)
The safety and efficacy of Rapamune as immunosuppressive therapy have not been established in liver or lung transplant patients, and therefore, such use is not recommended. Get the full prescribing information, today in Vidyya. more


Information for patients: Rapamune (sirolimus)
Rapamune (sirolimus) is an antirejection medication. It helps the body fight rejection of a transplanted kidney.  more

Latest Canadian numbers and information about SARS
As of April 12, 2003, Health Canada has received reports of 274 probable or suspect cases of severe acute respiratory syndrome (SARS) in Canada. There have been 13 deaths in Canada. All Canadian cases have occurred in persons who have traveled to Asia or had contact with SARS cases in the household or in a health-care setting. The information contained in this update is based on the best available information Health Canada has at this time. more

Severe Acute Respiratory Syndrome (SARS): Affected areas, status of SARS outbreaks in individual countries (International Update)
On Friday, WHO added Beijing, China to its list of SARS-affected areas. Areas are added to the list following indication that chains of local transmission are occurring. The greatest concern arises when cases occur outside the established risk groups of health care workers and persons in close face-to-face contact with patients, such as household contacts and hospital visitors.  more

little clear gif used for a space